Zhejiang Dayang Biotech Group Co Strategic Asset Allocation Index
Zhejiang Dayang Biotech Group Co strategic asset allocation index. Zhejiang Dayang Biotech Group Co (003017) has a Strategic Asset Allocation Index of 62.7% as of June 2023. Strategic assets (PP&E of CN¥631.19 Million plus long-term investments of CN¥-) total CN¥631.19 Million, measured against net assets of CN¥1.01 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Zhejiang Dayang Biotech Group Co balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Zhejiang Dayang Biotech Group Co (2016–2022)
Strategic asset allocation index of Zhejiang Dayang Biotech Group Co from 2016 to 2022. This chart shows how Zhejiang Dayang Biotech Group Co's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 62.7%, representing strategic assets of CN¥631.19 Million against net assets of CN¥1.01 Billion CNY. Check 003017 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Zhejiang Dayang Biotech Group Co Strategic Asset Allocation Index by Year (2016–2022)
Zhejiang Dayang Biotech Group Co strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Dayang Biotech Group Co from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Zhejiang Dayang Biotech Group Co (003017) total market value.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 62.6% | CN¥616.17 Million | CN¥616.17 Million | CN¥- | CN¥985.05 Million | ▲ +9.3 pp |
| 2021 | 53.3% | CN¥528.02 Million | CN¥528.02 Million | CN¥- | CN¥990.71 Million | ▲ +8.0 pp |
| 2020 | 45.3% | CN¥433.57 Million | CN¥433.57 Million | CN¥- | CN¥958.13 Million | ▼ -9.8 pp |
| 2019 | 55.0% | CN¥274.17 Million | CN¥274.17 Million | CN¥- | CN¥498.09 Million | ▼ -1.2 pp |
| 2018 | 56.2% | CN¥247.65 Million | CN¥247.65 Million | CN¥- | CN¥440.62 Million | ▼ -9.5 pp |
| 2017 | 65.7% | CN¥221.81 Million | CN¥221.81 Million | CN¥- | CN¥337.71 Million | ▼ -20.9 pp |
| 2016 | 86.6% | CN¥198.55 Million | CN¥198.55 Million | CN¥- | CN¥229.35 Million | — |